Sharda Cropchem Ltd. · NSE:SHARDACROP

Sharda Cropchem — Q4 FY26 Earnings Presentation

35 slides from Sharda Cropchem's earnings presentation, May 13, 2026

  1. Slide 1: Cover letter to stock exchanges

    13th May, 2026 To, National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoi Tower, Exchange Plaza, 5th Floor, Plot No. Dalal Street, C/1, Mumbai – 400 001 G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Trading Symbol: SHARDACROP Scrip Code: 538666 Subject: Investors / Ana

  2. Slide 2: Investor Presentation May 2026

    Investor Presentation May 2026 GROWING STRONGER, GOING FURTHER.

  3. Slide 3: Safe Harbor

    SAFE HARBOR This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or in

  4. Slide 4: About Sharda Cropchem Limited

    About Sharda Cropchem Limited

  5. Slide 5: “We are a fast-growing global agrochemicals company with a peer position in the crop

    “We are a fast-growing global agrochemicals company with a peer position in the crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North America and La

  6. Slide 6: Agrochemical Focused Company

    AGROCHEMICAL FOCUSED COMPANY Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency o

  7. Slide 7: Asset Light Business Model

    ASSET LIGHT BUSINESS MODEL Overall Agrochemical Value Chain Sharda’s Operating Area √ √ √ √ Basic & Applied Active Ingredient Formulation & Marketing & Identification Registration Research Manufacturing Packaging Distribution Highly flexible operating model Manufacturing of AIs and Focus on identifi

  8. Slide 8: Increasing Global Presence with Widespread Distribution

    INCREASING GLOBAL PRESENCE WITH WIDESPREAD DISTRIBUTION Presence Global Resource Distributors CAPEX incurred in FY26 80+ countries Deployment 525+ Rs. 505 Cr. across Europe, NAFTA, LATAM & RoW 500+ Over the years, the Company has built a strong brand franchise within our global markets; we are benef

  9. Slide 9: The Sharda Advantage

    The Sharda Advantage Healthy Global Reach Wide Product Relationships with Range Suppliers One Stop Solution Quality with Faster Sales Provider for Crop Affordability Service Care Products

  10. Slide 10: Way Forward

    WAY FORWARD 1 2 Forward Integration - Build Sales Force Expand & Strengthen Distribution Presence ✓ Leverage market presence and execution capabilities ✓ Adopt the factory to farmer approach and be a one stop ✓ Expand geographical reach using existing library of dossiers solution provider ✓ Two-fold

  11. Slide 11: Industry Outlook & Growth Drivers

    INDUSTRY OUTLOOK & GROWTH DRIVERS Global crop protection INDUSTRY DRIVERS (In Billion USD) – CAGR of 3.96% A Growing Population: Global population is projected to rise from 7.6 Bn in 2025 141.7 to 8.6 Bn by 2030 and 9.8 Bn by 2050 placing unprecedented pressure on global +3.96% food and protein syst

  12. Slide 12: Experienced Management

    Experienced Management Mr. Ramprakash V. Bubna Mr. Ashish Bubna Mr. Manish Bubna Chairman & Managing Director Whole Time Director Whole Time Director ✓ Holds a Bachelor’s Degree of Technology in Chemical ✓ Holds a Bachelor’s Degree in Commerce from the ✓ Holds a Bachelor’s Degree in Chemical Enginee

  13. Slide 13: Q4 FY26 Financial Highlights

    Q4 FY26 Financial Highlights

  14. Slide 14: Q4 FY26: Segment Wise Highlights

    Q4 FY26: SEGMENT WISE HIGHLIGHTS Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 92% 93% 8% 7% % of Revenue 100% 100% +14% 0.3% +13% 1,927 138 138 2,065 1,691 1,829 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 GROWING STRONGER, GOING FURTHER. On Consolidated Basis 13

  15. Slide 15: Q4 FY26: Product Wise Highlights

    Q4 FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 50% 46% 17% 19% 33% 35% % of Revenue 100% 100% +5% +21% +14% 896 +25% 669 1,927 850 1,691 361 552 288 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 G

  16. Slide 16: Q4 FY26: Region Wise Breakup (Agrochemical)

    Q4 FY26: REGION WISE BREAKUP (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 66% 70% 29% 24% +20% -6% +14% 1,342 493 461 1,927 1,115 1,691 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 LATAM Region RoW 2% 2% 3% 4% +17% +77% 46 79 39 44 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q

  17. Slide 17: Q4 FY26: Region Wise Breakup (Non-Agrochemical)

    Q4 FY26: REGION WISE BREAKUP (Non - Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 14% 10% 68% 69% -27% +1% +0.3% 20 94 95 138 138 14 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 LATAM Region RoW 8% 8% 10% 13% -1% +39% 11 11 18 13 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY

  18. Slide 18: Q4 FY26: Financial Highlights

    Q4 FY26 : FINANCIAL HIGHLIGHTS Cr. Revenues & GP Margin EBITDA Profit After Tax 29.8% 37.3% +75% +57% +13% 513 319 2,065 1,829 293 204 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 ✓ Revenue in Q4 FY26 increased by 13% driven by ✓ Gross Margins have improved by 750 basis points to 37.3%. These mar

  19. Slide 19: FY26 Financial Highlights

    FY26 Financial Highlights

  20. Slide 20: FY26: Segment Wise Highlights

    FY26: SEGMENT WISE HIGHLIGHTS Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 87% 90% 13% 10% % of Revenue 100% 100% +25% +1% +22% 4,717 547 551 5,268 3,773 4,320 FY25 FY26 FY25 FY26 FY25 FY26 GROWING STRONGER, GOING FURTHER. On Consolidated Basis 19

  21. Slide 21: FY26: Product Wise Highlights

    FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 53% 51% 19% 21% 28% 28% % of Revenue 100% 100% +21% +24% +25% 2,410 +39% 1,302 4,717 1,996 1,005 1,053 3,773 724 FY25 FY26 FY25 FY26 FY25 FY26 FY25 FY26 GROWING STRONGER,

  22. Slide 22: FY26: Region Wise Breakup (Agrochemical)

    FY26: REGION WISE BREAKUP (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 58% 63% 32% 27% +37% +3% +25% 2,981 1,227 1,266 4,717 2,177 3,773 FY25 FY26 FY25 FY26 LATAM Region RoW 5% 5% 5% 5% +33% +21% 254 216 191 178 FY25 FY26 FY25 FY26 FY25 FY26 % of Revenue GROWI

  23. Slide 23: FY26: Region Wise Breakup (Non-Agrochemical)

    FY26: REGION WISE BREAKUP (Non - Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 14% 16% 67% 66% +15% 0% +1% 89 367 366 547 551 77 FY25 FY26 FY25 FY26 LATAM Region RoW 9% 8% 10% 10% -10% -2% 47 43 55 54 FY25 FY26 FY25 FY26 FY25 FY26 % of Revenue GROWING STRO

  24. Slide 24: FY26: Financial Highlights

    FY26 : FINANCIAL HIGHLIGHTS Cr. Revenues & GP Margin EBITDA Profit After Tax 29.9% 35.9% +69% +124% +22% 1,040 681 5,268 4,320 613 304 FY25 FY26 FY25 FY26 FY25 FY26 ✓ Revenue in FY26 increased by ~22% primarily driven ✓ Gross Margins have improved 600 basis points to 35.9%. These margins are by sust

  25. Slide 25: Strong Balance Sheet

    STRONG BALANCE SHEET Working Capital (in Days) Total Equity^ 118 days 98 days Reduced Working Rs. 3,137 crores Capital by 20 days 146 151 Rs. 2,501 crores as on Mar’25 125 111 83 72 Mar-25 Mar-26 Cash, Bank & Liquid Inventory Days Recievable Days Creditor Days Investments^ RoCE* RoE* Rs. 702 crores

  26. Slide 26: Annexure

    Annexure

  27. Slide 27: Q4 & FY26 Financial Highlights

    Q4 & FY26 FINANCIAL HIGHLIGHTS Cr. Particulars Q4 FY26 Q4 FY25 Y-o-Y FY26 FY25 Y-o-Y Revenue from Operations 2,064.9 1,828.5 13% 5,267.6 4,319.9 22% COGS 1,294.7 1,284.5 3,377.2 3,028.1 Gross Profit 770.2 544.0 42% 1,890.4 1,291.8 46% Gross Margin % 37.3% 29.8% 35.9% 29.9% Employee Expenses 23.0 18.

  28. Slide 28: Balance Sheet

    BALANCE SHEET Cr. EQUITY & LIABILITIES Mar-26 Mar-25 ASSETS Mar-26 Mar-25 Equity Non-current assets Equity share capital 90.2 90.2 Property, plant and equipment 2.5 3.0 Other equity 3,046.3 2,410.3 Right to use assets 0.0 7.2 Equity attributable to equity holders of the Company 3,136.5 2,500.6 Non-c

  29. Slide 29: Cash Flow Statement

    CASH FLOW STATEMENT Cr. Particulars Mar-26 Mar-25 Profit Before Tax 855.5 378.3 Adjustments 319.1 286.8 Operating profit before working capital changes 1,174.6 665.1 Changes in working capital (453.9) (30.5) Cash generated from operations 720.7 634.6 Direct taxes paid (net of refund) (65.0) (31.0) N

  30. Slide 30: Key Financial Performance Indices

    KEY FINANCIAL PERFORMANCE INDICES Cr. Revenue EBITDA & EBITDA Margin Profit After Tax & PAT Margin 20.4% 17.6% 10.1% 15.8% 19.7% 9.8% 8.5% 1.0% 7.0% 12.9% 5,268 4,045 4,320 3,580 1,040 681 3,163 729 713 682 349 342 304 318 32 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26

  31. Slide 31: Historical Profit & Loss

    HISTORICAL PROFIT & LOSS Cr. Particulars FY26 FY25 FY24 FY23 FY22 Revenue from Operations 5,267.6 4,319.9 3,163.0 4,045.2 3,579.8 COGS 3,377.2 3,028.1 2,342.4 2,860.8 2,499.8 Gross Profit 1,890.4 1,291.8 820.6 1,184.4 1,080.0 Gross Margin % 35.9% 29.9% 25.9% 29.3% 30.2% Employee Expenses 66.7 52.0 4

  32. Slide 32: Balance Sheet – Equity & Liabilities

    BALANCE SHEET – EQUITY & LIABILITIES Cr. Equities & Liabilities Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 3,046.3 2,410.3 2,146.9 2,141.8 1,822.2 Non-controlling Interest 0.5 0.4 0.4 0.4 0.3 Total Equity 3,137.0 2,501.0 2,23

  33. Slide 33: Balance Sheet – Assets

    BALANCE SHEET – ASSETS Cr. ASSETS Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Assets Non-Current Assets Property, Plant and Equipment 2.5 3.0 3.8 5.0 14.4 Right to Use Assets 0.0 7.2 14.4 0.0 - Goodwill 0.0 0.0 0.0 0.0 0.0 Other Intangible assets 986.2 740.2 690.0 663.0 577.4 Intangible assets under developm

  34. Slide 34: CSR Activities

    CSR ACTIVITIES CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects Promoting Education Animal Welfare Medical Aid & Relief GROWING STRONGER, GOING FUR

  35. Slide 35: Thank You

    GROWING STRONGER, GOING FURTHER. THANK YOU Company: Sharda Cropchem Limited Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: L51909MH2004PLC145007 CIN: U74140MH2010PTC204285 Mr. Shailesh Mehendale – CFO Mr. Deven Dhruva / Mr. Ronak Jain cfo@shardaintl.com / finance@shardaintl.com

Sharda Cropchem — Q4 FY26 Earnings Presentation on 6ix